• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索尼娅·斯利夫卡纵向多发性硬化症研究:方法与样本特征

The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics.

作者信息

Minden S L, Frankel D, Hadden L, Perloffp J, Srinath K P, Hoaglin D C

机构信息

Department of Psychiatry, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Mult Scler. 2006 Feb;12(1):24-38. doi: 10.1191/135248506ms1262oa.

DOI:10.1191/135248506ms1262oa
PMID:16459717
Abstract

The Sonya Slifka Longitudinal Multiple Sclerosis Study follows a population-based cohort of approximately 2000 people with multiple sclerosis (MS) to study demographic and clinical characteristics, course of illness, utilization and cost of health services, provider characteristics, use of MS specialists and disease modifying agents, and neurologic, economic and psychosocial outcomes. This report describes the study methodology, presents baseline demographic and clinical data, and evaluates the representativeness of the sample. A stratified random sample of persons with established and recently-diagnosed MS selected from the National Multiple Sclerosis Society (NMSS) mailing lists was supplemented with recently-diagnosed patients recruited through systematic nationwide outreach. Baseline data were collected by computer-assisted telephone interviews derived from standardized instruments; data collection continues at six-month intervals. The cohort was comparable to population-based and clinical samples with respect to demographics, course, relapse rate, symptoms, and severity of disability. Almost two-thirds of the cohort needed help with activities of daily living, three-quarters were limited in work or other activities, and half had emotional problems that compromised quality of life. The Slifka Study cohort is broadly representative of the MS population and the database can be used to address questions not answered by natural history studies, clinical databases, or population-based surveys.

摘要

索尼娅·斯利夫卡纵向多发性硬化症研究跟踪了一个基于人群的队列,约2000名多发性硬化症(MS)患者,以研究人口统计学和临床特征、疾病进程、卫生服务的利用和成本、医疗服务提供者特征、MS专科医生和疾病修正药物的使用,以及神经学、经济学和社会心理结果。本报告描述了研究方法,呈现了基线人口统计学和临床数据,并评估了样本的代表性。从美国国家多发性硬化症协会(NMSS)邮件列表中选取的已确诊和近期确诊的MS患者分层随机样本,通过全国系统性外展招募的近期确诊患者进行了补充。基线数据通过源自标准化工具的计算机辅助电话访谈收集;数据收集每六个月进行一次。该队列在人口统计学、病程、复发率、症状和残疾严重程度方面与基于人群的样本和临床样本具有可比性。近三分之二的队列成员在日常生活活动中需要帮助,四分之三的人在工作或其他活动中受到限制,一半的人存在影响生活质量的情绪问题。斯利夫卡研究队列广泛代表了MS人群,该数据库可用于解决自然史研究、临床数据库或基于人群的调查未回答的问题。

相似文献

1
The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics.索尼娅·斯利夫卡纵向多发性硬化症研究:方法与样本特征
Mult Scler. 2006 Feb;12(1):24-38. doi: 10.1191/135248506ms1262oa.
2
Access to health care for people with multiple sclerosis.多发性硬化症患者获得医疗保健服务的情况。
Mult Scler. 2007 May;13(4):547-58. doi: 10.1177/1352458506071306. Epub 2007 Feb 9.
3
Disability in elderly people with multiple sclerosis: An analysis of baseline data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.老年多发性硬化症患者的残疾状况:索尼娅·斯利夫卡多发性硬化症纵向研究基线数据分析
NeuroRehabilitation. 2004;19(1):55-67.
4
Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.多发性硬化症患者的生活质量:来自索尼娅·斯利夫卡多发性硬化症纵向研究的数据。
J Health Hum Serv Adm. 2007 Winter;30(3):233-67.
5
Disease-modifying agents in the Sonya Slifka Longitudinal Multiple Sclerosis Study.索尼娅·斯利夫卡多发性硬化纵向研究中的疾病修饰药物。
Mult Scler. 2008 Jun;14(5):640-55. doi: 10.1177/1352458507086463.
6
Costs and quality of life of multiple sclerosis in the United Kingdom.英国多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104. doi: 10.1007/s10198-006-0380-z.
7
Costs and quality of life of multiple sclerosis in Sweden.瑞典多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S75-85. doi: 10.1007/s10198-006-0379-5.
8
Costs and quality of life of multiple sclerosis in Austria.奥地利多发性硬化症的成本与生活质量
Eur J Health Econ. 2006 Sep;7 Suppl 2:S14-23. doi: 10.1007/s10198-006-0382-x.
9
Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.多发性硬化症研究中的治疗经验、负担和未满足的需求(论坛):荷兰多发性硬化症患者的成本和效用。
J Med Econ. 2013 Jul;16(7):939-50. doi: 10.3111/13696998.2013.807267. Epub 2013 Jun 12.
10
Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009?索尼娅·斯利夫卡研究参与者使用疾病修饰疗法的情况及成本:自2000年和2009年以来真的有什么变化吗?
Mult Scler J Exp Transl Clin. 2019 Feb 20;5(1):2055217318820888. doi: 10.1177/2055217318820888. eCollection 2019 Jan-Mar.

引用本文的文献

1
Fatigue management effects on social participation and environment management in individuals with multiple sclerosis: Quasi-experimental study.疲劳管理对多发性硬化症患者社交参与和环境管理的影响:准实验研究。
Br J Occup Ther. 2025 Feb;88(2):93-104. doi: 10.1177/03080226241280860. Epub 2024 Oct 17.
2
Proximal Muscle Resistance Training to Improve Walking in People With Multiple Sclerosis: A Pilot Study.近端肌肉抗阻训练改善多发性硬化症患者的步行能力:一项试点研究。
J Neurol Phys Ther. 2024 Nov 25. doi: 10.1097/NPT.0000000000000504.
3
Understanding the mechanisms of fatigue in multiple sclerosis: linking interoception, metacognition and white matter dysconnectivity.
了解多发性硬化症疲劳的机制:连接内感受、元认知和白质连接障碍。
Brain Commun. 2024 Sep 11;6(5):fcae292. doi: 10.1093/braincomms/fcae292. eCollection 2024.
4
Validation of the Fatigue Impact Scale in Multiple Sclerosis Patients in Serbia.塞尔维亚多发性硬化症患者疲劳影响量表的验证
Brain Sci. 2024 Aug 17;14(8):825. doi: 10.3390/brainsci14080825.
5
Walking performance differs between people with multiple sclerosis who perform distinct types of exercise.进行不同类型锻炼的多发性硬化症患者的行走能力存在差异。
Neurodegener Dis Manag. 2024;14(3-4):75-85. doi: 10.1080/17582024.2024.2389037. Epub 2024 Aug 19.
6
Astrocyte Activation and Drug Target in Pathophysiology of Multiple Sclerosis.星形胶质细胞激活与多发性硬化症病理生理学中的药物靶点
Methods Mol Biol. 2024;2761:431-455. doi: 10.1007/978-1-0716-3662-6_30.
7
Long-term effectiveness of a cognitive behavioural therapy (CBT) in the management of fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a multicentre, randomised, open-label, controlled trial versus standard care.复发缓解型多发性硬化症(RRMS)患者疲劳管理中认知行为疗法(CBT)的长期疗效:一项多中心、随机、开放标签、对照试验与标准治疗的比较。
J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):158-166. doi: 10.1136/jnnp-2023-331537.
8
EDSS and infratentorial white matter lesion volume are considered predictors of fatigue severity in RRMS.EDSS 和小脑白质病变体积被认为是 RRMS 疲劳严重程度的预测因子。
Sci Rep. 2023 Jul 14;13(1):11404. doi: 10.1038/s41598-023-38368-3.
9
Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study.将多维计算机化自适应测试应用于 MSQOL-54:一项模拟研究。
Health Qual Life Outcomes. 2023 Jun 25;21(1):61. doi: 10.1186/s12955-023-02152-8.
10
Development of a behavioural intervention for cognitive fatigability in multiple sclerosis: Protocol for a pilot and feasibility study.多发性硬化症认知疲劳行为干预措施的开发:一项试点及可行性研究方案
Front Rehabil Sci. 2022 Nov 16;3:999266. doi: 10.3389/fresc.2022.999266. eCollection 2022.